Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM) - correlation with prognostic factors

Cancer/testis (CT) antigens are potential targets for cancer immunotherapy, with NY-ESO-1 being among the most immunogenic. In several clinical trials in malignant melanoma (MM) patients, NY-ESO-1 protein/peptides showed clear evidence of inducing specific immunity. However, little is known about NY...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Velazquez, Elsa F., Jungbluth, Achim A., Yancovitz, Molly, Gnjatic, Sacha, Adams, Sylvia, O'Neill, David, Zavilevich, Kira, Albukh, Tatyana, Christos, Paul, Mazumdar, Madhu, Pavlick, Anna, Polsky, David, Shapiro, Richard, Berman, Russell, Spira, Joanna, Busam, Klaus, Osman, Iman, Bhardwaj, Nina
Formato: Artigo
Idioma:Inglês
Publicado em: Academy of Cancer Immunology 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935749/
https://ncbi.nlm.nih.gov/pubmed/17625806
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados